This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Stanley Bauer, MD
The Bronx-Lebanon Hospital Center Bronx, NY

JAMA. 1989;262(11):1470-1471.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Until recently, if a health care worker was exposed to the blood or body fluids of a human immunodeficiency virus (HIV)-infected individual little was done except to counsel the worker and follow up the worker for evidence of HIV infection. If the HIV status of the source patient is not known, the Centers for Disease Control, Atlanta, Ga, has recommended that informed consent be obtained to test for HIV antibodies. Moreover, informed consent for HIV antibody testing is required by many states.

However, there now is positive action that may be taken after accidental exposure. There is evidence based on animal studies that zidovudine, alone or in combination with interferon alfa, can prevent or alter experimental retrovirus infection and that the effectiveness of zidovudine in preventing disease is greatest when it is administered soon after inoculation rather than after a delay.^1-4 The National Institutes of Health, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?